Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial

BACKGROUND: Intrauterine infection and/or inflammation (Triple I) is an important cause of preterm birth (PTB) and adverse newborn outcomes. N-acetylcysteine (NAC) is a Food and Drug Administration (FDA)-approved drug safely administered to pregnant women with acetaminophen toxicity. METHODS: We con...

Full description

Saved in:
Bibliographic Details
Published in:Pediatr Res
Main Authors: Buhimschi, Catalin S., Bahtiyar, Mert Ozan, Zhao, Guomao, Abdelghany, Osama, Schneider, Lydia, Razeq, Sonya Abdel, Dulay, Antonette T., Lipkind, Heather S., Mieth, Saya, Rogers, Lynette, Bhandari, Vineet, Buhimschi, Irina A.
Format: Artigo
Language:Inglês
Published: Nature Publishing Group US 2020
Subjects:
Clinical Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7451831/
https://ncbi.nlm.nih.gov/pubmed/32818949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41390-020-01106-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items